Allergy Therapeutics plc (LON:AGY – Get Free Report)’s share price hit a new 52-week low during trading on Thursday . The stock traded as low as GBX 5 and last traded at GBX 5.90, with a volume of 143181 shares changing hands. The stock had previously closed at GBX 5.50.
Allergy Therapeutics Price Performance
The firm’s fifty day moving average price is GBX 7.82 and its 200 day moving average price is GBX 9.82. The firm has a market capitalization of £373.62 million, a PE ratio of -6.08, a P/E/G ratio of -30.70 and a beta of 0.87. The company has a current ratio of 1.13, a quick ratio of 1.48 and a debt-to-equity ratio of 629.58.
About Allergy Therapeutics
Allergy Therapeutics is an international commercial biotechnology company focussed on the treatment and diagnosis of allergic disorders, including aluminium free immunotherapy vaccines that have the potential to cure disease. The Group sells proprietary and third party products from its subsidiaries in nine major European countries and via distribution agreements in an additional ten countries. Its broad pipeline of products in clinical development include vaccines for grass, tree and house dust mite, and peanut allergy vaccine in pre-clinical development.
See Also
- Five stocks we like better than Allergy Therapeutics
- Premium Retail’s Stress Test Is Separating Winners From Losers
- D-Wave Quantum or a Quantum ETF: Which Is the Better Bet?
- GE Vernova Just Sent a Mixed AI Signal to Investors
- Alphabet Crushed Earnings, But One Number Spooked the Market
Receive News & Ratings for Allergy Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allergy Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
